CPhI Worldwide 2018: PharmaNutra’s debut at the pharmaceutical event of the year
The 2018 edition of CPhI Worldwide, the most important trade fair in the world for the pharmaceutical sector, ended yesterday afternoon. From 9 to 11 October, more than 2,500 exhibitors and over 45,000 professionals in the sector gathered in Madrid. Among these, PharmaNutra SPA did not go unnoticed, but despite its first experience as an exhibiting company, it found a remarkable success in terms of visibility and turnout at its stand.
The essential but modern design of the stand has attracted visitors from all over the world, interested to discover the products on display: on one hand the Cetilar® line, presented for the first time to the international public, and on the other hand the SiderAL® line, already well established abroad but with an ever expanding range.
“We have found an extremely positive feedback”, commented the President of PharmaNutra SPA, Andrea Lacorte, “the CPhI gave us an opportunity to consolidate relations with our international partners, but above all we noted a great interest from countries where we are not present still as South America, Central Africa, Pakistan, South Korea, the United States and Canada. In addition, for the first time we have presented the Cetilar® line to foreign markets and with satisfaction we can say that already about twenty countries are interested in the distribution of these products. All the staff of the foreign office was present at CPhI and did a fantastic job, which however is only at the beginning”.
Success also confirmed by the words of Roberta Romani, Export Manager of PharmaNutra for outside Europe markets, who comments: “Per PharmaNutra it was time to present our products to the pharmaceutical sector and we could not have chosen a more important stage than CPhI. The SiderAL® line falls into the nutraceutical category in reality, but the innovation and scientific research behind the Sucrosomial Technology has made SiderAL® a product primarily for the medical profession. The great revelation was Cetilar®, for which we received numerous requests despite being a completely new medical device internationally. We can not but be satisfied with the reception reserved for us in what, scientifically speaking, is an environment in which the level of visitors and companies taking part is very high. At the moment it is difficult to quantify precisely the number of visits to our stand, we will analyze the concrete results after the follow up process, in the meantime we are already working on our participation in the CPhI Worldwide 2019 in Frankfurt”.